Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.170
-0.005 (-0.43%)
At close: Jul 10, 2025, 4:00 PM
1.190
+0.020 (1.71%)
After-hours: Jul 10, 2025, 5:47 PM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $34.82 million as of July 10, 2025. Its market cap has decreased by -77.60% in one year.
Market Cap
34.82M
Enterprise Value
34.51M
1-Year Change
-77.60%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $34.82M, a decrease of -83.20%. That is a compound annual growth rate of -71.68%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 9, 2025 | 34.97M | -71.47% |
Dec 31, 2024 | 122.58M | -40.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 709.79B |
Johnson & Johnson | 379.41B |
AbbVie | 344.45B |
Novo Nordisk | 316.64B |
UnitedHealth Group | 271.70B |
Novartis AG | 243.81B |
Abbott Laboratories | 232.44B |
AstraZeneca | 223.49B |